Trial register facet
Trial records for Larazotide acetate
8 records for Larazotide acetate, of which 2 are published trials.
Showing 0 records on this page
Records
8 documents
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| CELIAC-PH3-CEDLARA | Larazotide acetate | Phase 3 | Terminated | Randomised, double-blind, placebo-controlled | — | 2022 | Not rated |
| CELIAC-PH3-CEDLARA-BODY-COMPprogramme record | Larazotide acetate | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2022 | Very low |
| CELIAC-PH3-CEDLARA-REGIONAL-JPprogramme record | Larazotide acetate | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2022 | Very low |
| CELIAC-PH2B | Larazotide acetate | Phase 2b | Reported | Randomised, double-blind, placebo-controlled | 342 | 2015 | Moderate |
| CELIAC-PH2B-PKprogramme record | Larazotide acetate | Phase 1 | Reported | Phase 1 ascending dose | — | 2015 | Very low |
| CELIAC-PH2B-RENAL-IMPprogramme record | Larazotide acetate | Phase 1 | Reported | Phase 1 ascending dose | — | 2015 | Very low |
| CELIAC-PH2B-HEPATIC-IMPprogramme record | Larazotide acetate | Phase 1 | Reported | Phase 1 ascending dose | — | 2015 | Very low |
| CELIAC-PH2B-DDIprogramme record | Larazotide acetate | Phase 1 | Reported | Randomised crossover | — | 2015 | Very low |